Tatva Chintan Pharma Chem Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
TATVA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Tatva Chintan Pharma Chem has submitted a routine quarterly compliance certificate to BSE and NSE for the quarter ending 30 June 2025, as required under SEBI's Depositories Regulations. The certificate was issued by MUFG Intime India (formerly Link Intime), the company's Registrar and Share Transfer Agent. It confirms that all dematerialisation requests received from depository participants during the quarter were properly processed, and that physical share certificates received were mutilated, cancelled, and the depository's name substituted in the register of members within prescribed timelines.
This is a purely procedural regulatory filing with no material impact on the business, financials, or share price. It simply confirms routine share transfer activities were handled correctly during the quarter.